VANGUARD HEALTH CARE FUND (VGHAX) is an MF managed by Vanguard. Its largest position is ELI LILLY & Co (LLY), representing 9.08% of fund assets.
VANGUARD HEALTH CARE FUND Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- VGHAX
- Type:
- MF
- Manager:
- Vanguard
- Total Assets:
- —
- Report Date:
- Apr 30, 2026
- Filing Date:
- Jun 26, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ELI LILLY & Co
|
9.08% | $3,348,515,721.80 | 3,582,833 |
|
-
Merck & Co., Inc.
|
5.41% | $1,995,785,834.50 | 18,279,775 |
|
-
ASTRAZENECA PLC
|
5.09% | $1,877,713,911.27 | 9,897,175 |
|
-
UNITEDHEALTH GROUP INC
|
3.92% | $1,443,133,337.36 | 3,895,307 |
|
-
JOHNSON & JOHNSON
|
3.45% | $1,270,455,421.40 | 5,527,324 |
|
-
Edwards Lifesciences Corp
|
3.21% | $1,182,247,442.00 | 14,158,652 |
|
-
GSK plc
|
3.13% | $1,153,636,373.67 | 44,002,585 |
|
-
INTUITIVE SURGICAL INC
|
2.71% | $1,000,640,228.26 | 2,186,666 |
|
-
BOSTON SCIENTIFIC CORP
|
2.36% | $868,207,933.18 | 15,070,438 |
|
-
DANAHER CORP /DE/
|
2.35% | $865,486,843.35 | 4,836,473 |
|
-
CVS HEALTH Corp
|
2.20% | $812,625,381.62 | 9,756,578 |
|
-
ARGENX SE
|
2.20% | $812,574,396.64 | 1,036,146 |
|
-
ABBOTT LABORATORIES
|
2.18% | $802,765,633.95 | 8,842,005 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
2.09% | $770,104,142.22 | 1,801,919 |
|
-
Cencora, Inc.
|
2.08% | $765,235,752.51 | 2,484,451 |
|
-
Elevance Health, Inc.
|
1.90% | $699,524,247.62 | 1,858,361 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
1.79% | $658,899,315.16 | 931,886 |
|
-
UCB SA
|
1.74% | $641,366,325.21 | 2,355,442 |
|
-
NOVARTIS AG
|
1.62% | $597,538,313.30 | 4,043,167 |
|
-
HCA Healthcare, Inc.
|
1.42% | $522,821,474.50 | 1,203,410 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
1.40% | $517,058,443.71 | 1,670,679 |
|
-
AbbVie Inc.
|
1.35% | $497,893,587.84 | 2,356,112 |
|
-
BIOGEN INC.
|
1.30% | $478,139,640.16 | 2,526,097 |
|
-
UNITED THERAPEUTICS Corp
|
1.28% | $470,161,629.60 | 822,896 |
|
-
APPLIED MATERIALS INC /DE
|
1.27% | $467,551,954.78 | 2,228,631 |
|
-
APPLIED MATERIALS INC /DE
|
1.25% | $458,960,041.70 | 8,606,142 |
|
-
APPLIED MATERIALS INC /DE
|
1.24% | $457,404,307.93 | 1,122,465 |
|
-
APPLIED MATERIALS INC /DE
|
1.23% | $452,394,129.33 | 6,207,200 |
|
-
CARDINAL HEALTH INC
|
1.21% | $446,960,438.24 | 2,317,298 |
|
-
AGILENT TECHNOLOGIES, INC.
|
1.20% | $441,888,852.10 | 3,824,222 |
|
-
SHIONOGI & CO LTD
|
1.12% | $412,940,923.81 | 20,439,649 |
|
-
DEXCOM INC
|
1.03% | $379,046,469.00 | 6,365,180 |
|
-
APPLIED MATERIALS INC /DE
|
1.00% | $368,337,295.77 | 22,675,166 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
0.97% | $357,158,077.20 | 745,695 |
|
-
GENMAB A/S
|
0.97% | $356,374,265.00 | 1,345,944 |
|
-
Medtronic plc
|
0.93% | $342,351,524.16 | 4,228,128 |
|
-
STRYKER CORP
|
0.83% | $305,836,816.30 | 970,510 |
|
-
IONIS PHARMACEUTICALS INC
|
0.77% | $284,325,811.56 | 3,803,181 |
|
-
Revolution Medicines, Inc.
|
0.72% | $264,950,784.48 | 1,838,404 |
|
-
Ascendis Pharma A/S
|
0.65% | $240,835,695.96 | 1,049,942 |
|
-
STERIS plc
|
0.64% | $237,011,018.48 | 1,092,821 |
|
-
INCYTE CORP
|
0.61% | $225,372,617.40 | 2,365,620 |
|
-
APPLIED MATERIALS INC /DE
|
0.61% | $225,269,438.94 | 6,514,443 |
|
-
CYTOKINETICS INC
|
0.60% | $222,782,817.58 | 3,482,614 |
|
-
BRISTOL MYERS SQUIBB CO
|
0.60% | $221,858,707.01 | 3,661,639 |
|
-
APPLIED MATERIALS INC /DE
|
0.60% | $219,686,604.13 | 7,339,417 |
|
-
MADRIGAL PHARMACEUTICALS, INC.
|
0.57% | $211,570,084.02 | 408,918 |
|
-
ICON PLC
|
0.49% | $182,004,556.30 | 1,538,110 |
|
-
NOVO NORDISK A S
|
0.48% | $175,733,846.98 | 4,131,421 |
|
-
CG Oncology, Inc.
|
0.47% | $172,806,411.52 | 2,589,248 |
Advertisement (320x50)